2018
|
Invention
|
Antibody-drug conjugates targeted at human aspartyl-(asparaginyl)-b-hydroxylase (haah). Disclosed... |
|
Invention
|
Haah and mmp-9 are complementary cancer biomarkers and predictors of metastasis when combined. Th... |
2016
|
Invention
|
Radio-imaging and radio-therapy of cancer using antibodies to haah. The present invention is dire... |
2015
|
Invention
|
Recovery of aspartyl (asparaginyl) beta hydroxylase (haah) from an exosomal fraction of human ser... |
2009
|
Invention
|
Methods for the treatment of brain edema. The present invention is based on the discoveries that ... |
|
Invention
|
Determinants of antiviral response. The present invention relates to antiretroviral drug suscepti... |
2008
|
Invention
|
Anti-hiv compounds. Thiazole derivatives represented by Formula (I) are disclosed, where R1, R2, ... |
|
Invention
|
Furin-cleavable peptide linkers for drug-ligand conjugates. Disclosed are certain peptide linkers... |
|
Invention
|
Liquid bevirimat dosage forms for oral administration. The present application discloses and clai... |
|
Invention
|
Alpha-substituted arylmethyl piperazine pyrazolo[1,5-α]pyrimidine amide derivatives. Deriva... |
|
Invention
|
Alpha-unsubstituted arylmethyl piperazine pyrazolo[1,5-a] pyrimidine amide derivatives. Methods o... |
|
Invention
|
Salts of 3-o-(3',3'-dimethylsuccinyl)betulinic acid and solid state forms thereof. The present in... |
2007
|
Invention
|
Methods of neuroprotection by cyclin-dependent kinase inhibition |
|
Invention
|
Extended triterpene derivatives. The present invention concerns novel pharmaceutically active tri... |
|
Invention
|
Methods of diagnosing, predicting therapeutic efficacy and screening for new therapeutic agents f... |
2006
|
Invention
|
Preparation of pharmaceutical salts of 3-o-(3',3'-dimethlsuccinyl) betulinic acid. This... |
|
Invention
|
Methods of treating ischemic related conditions. The present invention relates to methods of trea... |
|
Invention
|
Polymorphs of 3-o-(3',3'-dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine. The ... |
2005
|
Invention
|
Novel betulin derivatives, preparation thereof and use thereof. The present invention relates to ... |
|
Invention
|
Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof. Betulin... |
|
Invention
|
Disruption of the processing of the viral capsid-spacer peptide 1 protein. Inhibition of HIV-1 re... |
|
Invention
|
Pharmaceuticals salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid. Salts of 3-O-(3&a... |
2004
|
Invention
|
Novel triterpene derivatives, preparation thereof and use thereof. The present invention relates ... |
|
Invention
|
Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptid... |
2003
|
Invention
|
Method for detecting viral inactivating agents. The invention is directed to methods for identify... |
2002
|
Invention
|
Compositions and methods for preventing protein aggregation in neurodegenerative diseases. Disclo... |
|
Invention
|
Methods of treating prion disease in mammals comprising administering a chaotropic agent such as ... |
|
Invention
|
Methods for treating neurodegenerative diseases including alzheimer's. Method for preventing neur... |
|
Invention
|
Substituted 3',4'-di-o-camphanoyl-(+)-cis-khellactone analogs, compositions thereof, and method... |
2001
|
Invention
|
Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases. Th... |
|
Invention
|
Olfactory neuron cultures and method of making and using the same. Olfactory neuron cultures and ... |
|
Invention
|
A method for generating immunogens that elicit neutralizing antibodies against fusion-active regi... |
|
Invention
|
Assay for detection of viral fusion inhibitors. The invention is directed to methods for identify... |
2000
|
Invention
|
Methods of eliciting broadly neutralizing antibodies targeting hiv-1 gp41. The present invention ... |
1999
|
Invention
|
Acylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof. Betulin and... |